NOCIL Limited Share Analysis - Start of upward Cycle? #nocil #nocilshare...

-

Comments

Post a Comment

Popular posts from this blog

Aarti Surfactants Ltd, an investment opportunity or bubble?

-
Image
Little Background      Aarti Surfactants Ltd was formed after demerger with Aarti Industries. The home and personal care segment of Aarti Industries was not doing well so management decided to split it, for every 10 shares held by Aarti Industries investor they got an option of either getting one equity or redeemable preference share of Aarti Surfactants. The demerger was approved in June 2019 by NCLT and the demerged entity got listed in July 2020. Now you already know the promoters are great and they have created wealth for investors. Turnaround      The company was loss-making in FY18-19, but they made a profit of 2.09 crore in FY19-20 as compared to a Net Loss of 6.47 crore in FY18-19 which implies demerger was a good call by promoters and it worked. Company Overview      Aarti surfactant is one of the leading producers of ionic and non-ionic surfactants and specialty products. What are surfactants you ask?      Well, surfactants are surface-active agents that reduce the surface t
Read more

SHILPA MEDICARE - A Company with a Vision?

-
Image
  SHILPA MEDICARE - A Company with a Vision?      We are going to discuss a company whose founder is known for his vision, analytical thinking, and taking different routes than the rest. Management      Shilpa medicare was founded by Mr. Vishnukant C. Bhutada in 1987, having its first contract manufacturing unit in Raichur, Karnataka. Back then Ahmedabad, Mumbai, and Hyderabad were top cities for Pharma companies yet he started his unit in Raichur and did face challenges in finding manpower but the rest is history.      He was born in a Maheshwari Marwari Family and against the community trend of doing B.com and joining family Business, he decided to pursue B. Pharma and post that founded Shilpa Medicare. His family was in the business of textiles so Pharma was something different he pursued.      Although the company started with contract manufacturing, slowly they entered API (Active Pharmaceutical Ingredients) business. In 2000 when all major pharma companies were trying to focus on
Read more

SOLARA ACTIVE PHARMA, A Pure API Player with vision for CRAMS

-
Image
Brief Background Arun Kumar, who is a common promoter for Strides Shasun and Sequent Scientific (both are listed in the market) decided to create a new company which would focus purely on APIs, as the APIs were low margin business and making it difficult to maintain margin, with this goal in mind he demerged the low margin API(Ibuprofen, Gabapentin, and Ranitidine, etc..) business of Strides Shasun and Human API business of Sequent Scientific to create SOLARA ACTIVE PHARMA, which would be a pure API company.     In March 2017, the board of directors of Strides and Sequent approved the demerger, and in March 2018, the scheme got approved by NCLT and the company got listed on June 27, 2018.     According to the deal, for every 6 shares held in Strides, 1 share of Solara was allotted and for every 25 shares held in Sequent, 1 share of Solara was allotted.     Strides Shasun retained the formulation business and High Margin API business, and Sequent Scientific retained the Animal Health AP
Read more